Azitra is trading at $0.14, up +5.62% in pre-market, with no identified company-specific explanation for the October 7 move.
- Supplied price context reports the pre-market move above the prior close.
- Azitra’s latest reported news was its October 1 update that ATR04-484 could advance to Cohort 2 after a safety review; that news predates the move and does not establish its cause.
- Broader markets are mixed to slightly lower pre-market, with no clear market-wide catalyst indicated.